$2.49 Billion is the total value of Redmile Group, LLC's 78 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 39.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Buy | ARRAY BIOPHARMA INC | $234,543,000 | -3.0% | 16,459,128 | +3.5% | 9.43% | +26.8% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $153,364,000 | -12.1% | 4,414,617 | +4.6% | 6.17% | +14.9% |
| FATE | FATE THERAPEUTICS INC | $132,915,000 | -21.2% | 10,359,666 | 0.0% | 5.34% | +2.9% | |
| XNCR | Buy | XENCOR INC | $111,543,000 | -5.5% | 3,084,703 | +1.8% | 4.49% | +23.5% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $94,069,000 | -17.2% | 2,237,607 | -1.6% | 3.78% | +8.2% |
| ARGX | Sell | ARGENX SEsponsored adr | $92,320,000 | +24.9% | 960,961 | -1.4% | 3.71% | +63.3% |
| ALLK | Buy | ALLAKOS INC | $88,788,000 | +35.2% | 1,698,648 | +16.4% | 3.57% | +76.7% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $79,736,000 | -21.5% | 8,323,217 | -0.9% | 3.21% | +2.6% |
| IFRX | Buy | INFLARX NV | $74,027,000 | +6.5% | 2,035,400 | +0.5% | 2.98% | +39.2% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $72,927,000 | +39.6% | 4,060,529 | +128.3% | 2.93% | +82.5% |
| WMGI | Buy | WRIGHT MED GROUP N V | $69,065,000 | +9.5% | 2,537,300 | +16.7% | 2.78% | +43.1% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $66,684,000 | -38.4% | 6,505,766 | 0.0% | 2.68% | -19.5% | |
| RGNX | Sell | REGENXBIO INC | $56,831,000 | -54.5% | 1,354,742 | -18.2% | 2.29% | -40.6% |
| CI | New | CIGNA CORP NEW | $52,344,000 | – | 275,610 | +100.0% | 2.10% | – |
| IMGN | Sell | IMMUNOGEN INC | $52,246,000 | -55.2% | 10,884,607 | -11.6% | 2.10% | -41.4% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $49,072,000 | -44.7% | 2,301,667 | +2.6% | 1.97% | -27.7% |
| LIVN | Sell | LIVANOVA PLC | $47,106,000 | -36.6% | 514,987 | -14.1% | 1.89% | -17.1% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $44,427,000 | – | 854,700 | +100.0% | 1.79% | – |
| EHTH | Sell | EHEALTH INC | $41,931,000 | +0.8% | 1,091,395 | -25.9% | 1.69% | +31.7% |
| XERS | Buy | XERIS PHARMACEUTICALS INC | $41,015,000 | -3.3% | 2,412,641 | +0.0% | 1.65% | +26.4% |
| EPZM | Buy | EPIZYME INC | $40,886,000 | +71.6% | 6,637,278 | +195.2% | 1.64% | +124.3% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $40,460,000 | -11.4% | 1,761,407 | -0.7% | 1.63% | +15.8% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $39,479,000 | -13.8% | 1,039,750 | -2.8% | 1.59% | +12.6% |
| MDT | New | MEDTRONIC PLC | $38,194,000 | – | 419,900 | +100.0% | 1.54% | – |
| QURE | Sell | UNIQURE NV | $37,565,000 | -37.1% | 1,303,422 | -20.5% | 1.51% | -17.7% |
| GRTS | Buy | GRITSTONE ONCOLOGY INC | $35,058,000 | +9.8% | 2,269,136 | +1.2% | 1.41% | +43.6% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $34,700,000 | -39.3% | 1,653,180 | +12.0% | 1.40% | -20.6% |
| ANTM | Sell | ANTHEM INC | $30,334,000 | -52.7% | 115,500 | -50.6% | 1.22% | -38.2% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $28,773,000 | -25.8% | 115,500 | -20.8% | 1.16% | -3.1% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $28,468,000 | -21.5% | 2,227,507 | -0.4% | 1.14% | +2.6% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $28,202,000 | – | 1,828,900 | +100.0% | 1.13% | – |
| CVS | Sell | CVS HEALTH CORP | $25,055,000 | -19.3% | 382,400 | -3.0% | 1.01% | +5.5% |
| VAPO | New | VAPOTHERM INC | $24,878,000 | – | 1,247,025 | +100.0% | 1.00% | – |
| ANAB | Sell | ANAPTYSBIO INC | $23,223,000 | -63.1% | 364,050 | -42.2% | 0.93% | -51.7% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $23,208,000 | -30.0% | 2,948,865 | -1.5% | 0.93% | -8.5% |
| ARRAY BIOPHARMA INCnote 2.625%12/0 | $22,845,000 | -3.7% | 19,000,000 | 0.0% | 0.92% | +25.9% | ||
| MOR | Sell | MORPHOSYS AGsponsored ads | $22,605,000 | -5.9% | 895,600 | -0.5% | 0.91% | +23.0% |
| REPL | Sell | REPLIMUNE GROUP INC | $21,890,000 | -38.0% | 2,188,957 | -0.2% | 0.88% | -19.0% |
| ICUI | Sell | ICU MED INC | $20,970,000 | -59.2% | 91,321 | -49.8% | 0.84% | -46.7% |
| NITE | Sell | NIGHTSTAR THERAPEUTICS PLCadr | $20,688,000 | -51.3% | 1,795,846 | -13.7% | 0.83% | -36.4% |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $19,989,000 | -25.9% | 25,000,000 | 0.0% | 0.80% | -3.1% | ||
| GLYC | Sell | GLYCOMIMETICS INC | $18,737,000 | -36.5% | 1,978,547 | -3.4% | 0.75% | -16.9% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $17,914,000 | -18.7% | 194,800 | -2.6% | 0.72% | +6.2% |
| PEN | Sell | PENUMBRA INC | $17,793,000 | -45.3% | 145,608 | -32.9% | 0.72% | -28.4% |
| HSKA | Sell | HESKA CORP | $17,023,000 | -58.5% | 197,713 | -45.3% | 0.68% | -45.7% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $16,943,000 | +6245.7% | 136,680 | +8496.2% | 0.68% | +8412.5% |
| SIBN | New | SI BONE INC | $13,388,000 | – | 640,900 | +100.0% | 0.54% | – |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $11,744,000 | +35.6% | 853,500 | -1.6% | 0.47% | +77.4% |
| TCDA | Sell | TRICIDA INC | $11,616,000 | -23.2% | 492,600 | -0.5% | 0.47% | +0.4% |
| TDOC | Sell | TELADOC HEALTH INC | $9,696,000 | -66.5% | 195,600 | -41.6% | 0.39% | -56.1% |
| LOGC | New | LOGICBIO THERAPEUTICS INC | $9,477,000 | – | 911,287 | +100.0% | 0.38% | – |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $9,188,000 | -53.4% | 1,649,538 | -0.4% | 0.37% | -39.0% |
| ATRC | New | ATRICURE INC | $9,180,000 | – | 300,000 | +100.0% | 0.37% | – |
| CMRX | Sell | CHIMERIX INC | $9,162,000 | -34.4% | 3,564,950 | -0.7% | 0.37% | -14.4% |
| AXNX | New | AXONICS MODULATION TECH INC | $9,066,000 | – | 600,000 | +100.0% | 0.36% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $6,880,000 | – | 167,600 | +100.0% | 0.28% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $6,754,000 | – | 325,000 | +100.0% | 0.27% | – |
| ODT | Sell | ODONATE THERAPEUTICS INC | $6,434,000 | -45.2% | 456,951 | -24.5% | 0.26% | -28.3% |
| NVTA | INVITAE CORP | $5,811,000 | -33.9% | 525,375 | 0.0% | 0.23% | -13.3% | |
| BGNE | Buy | BEIGENE LTDsponsored adr | $5,667,000 | -18.3% | 40,400 | +0.2% | 0.23% | +6.5% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $3,898,000 | +7.8% | 142,167 | -5.2% | 0.16% | +41.4% |
| OVID | Buy | OVID THERAPEUTICS INC | $1,785,000 | -56.9% | 737,550 | +1.0% | 0.07% | -43.3% |
| ARVN | ARVINAS INC | $1,751,000 | -23.8% | 136,300 | 0.0% | 0.07% | -1.4% | |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $864,000 | -68.8% | 256,473 | -39.7% | 0.04% | -58.8% |
| ELGX | Sell | ENDOLOGIX INC | $575,000 | -62.9% | 800,477 | -1.2% | 0.02% | -52.1% |
| LHCG | Sell | LHC GROUP INC | $394,000 | -98.2% | 4,200 | -98.1% | 0.02% | -97.7% |
| MYOK | Buy | MYOKARDIA INC | $387,000 | -17.1% | 7,930 | +10.6% | 0.02% | +14.3% |
| RGEN | Sell | REPLIGEN CORP | $317,000 | -71.4% | 6,020 | -69.9% | 0.01% | -61.8% |
| VCEL | Sell | VERICEL CORP | $291,000 | +2.8% | 16,720 | -16.4% | 0.01% | +33.3% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $275,000 | – | 2,820 | +100.0% | 0.01% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $283,000 | -7.8% | 2,950 | +35.9% | 0.01% | +22.2% |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $272,000 | – | 3,910 | +100.0% | 0.01% | – |
| FLXN | FLEXION THERAPEUTICS INC | $150,000 | -39.5% | 13,260 | 0.0% | 0.01% | -25.0% | |
| VKTX | Sell | VIKING THERAPEUTICS INC | $124,000 | -76.3% | 16,260 | -45.8% | 0.01% | -68.8% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $70,000 | -48.1% | 22,236 | 0.0% | 0.00% | -25.0% | |
| ACRS | ACLARIS THERAPEUTICS INC | $84,000 | -48.8% | 11,320 | 0.0% | 0.00% | -40.0% | |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $56,000 | – | 12,500 | +100.0% | 0.00% | – |
| CSLT | CASTLIGHT HEALTH INCcl b | $22,000 | -21.4% | 10,229 | 0.0% | 0.00% | 0.0% | |
| SENS | Exit | SENSEONICS HLDGS INC | $0 | – | -44,900 | -100.0% | -0.01% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -2,725 | -100.0% | -0.01% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -10,850 | -100.0% | -0.01% | – |
| IHF | Exit | ISHARES TRus hlthcr pr etf | $0 | – | -2,087 | -100.0% | -0.01% | – |
| RMED | Exit | RA MED SYS INC | $0 | – | -85,000 | -100.0% | -0.05% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -180,999 | -100.0% | -0.18% | – |
| IIN | Exit | INTRICON CORP | $0 | – | -125,000 | -100.0% | -0.22% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -634,400 | -100.0% | -0.32% | – |
| ELAN | Exit | ELANCO ANIMAL HEALTH INC | $0 | – | -525,000 | -100.0% | -0.56% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -306,400 | -100.0% | -0.66% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -428,473 | -100.0% | -0.68% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -253,300 | -100.0% | -0.71% | – |
| PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -1,450,925 | -100.0% | -0.86% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -668,850 | -100.0% | -0.94% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -439,700 | -100.0% | -0.96% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -221,745 | -100.0% | -0.99% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -252,100 | -100.0% | -1.13% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -155,909 | -100.0% | -1.54% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -370,200 | -100.0% | -2.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.